Inter partes review (IPR) is a legal process conducted before the Patent Trial and Appeal Board (PTAB) to assess patentability based on anticipation or obviousness using prior art publications and patents. This article discusses some practice tips for both challenging and defending patents in IPRs before the PTAB.
HRSA the federal agency responsible for administering the 340B drug pricing program – did not comply with the Administrative Procedure Act when it issued a May 17, 2021 letter to AstraZeneca to enforce the use of contract pharmacies under the 340B statute
HRSA the federal agency responsible for administering the 340B drug pricing program – did not comply with the Administrative Procedure Act when it issued a May 17, 2021 letter to AstraZeneca to enforce the use of contract pharmacies under the 340B statute